Disparities in outcomes for African American and Latino subjects in the Flexible Initial Retrovirus Suppressive Therapies (first) trial

Thomas P. Giordano, Glenn Bartsch, Yafeng Zhang, Ellen Tedaldi, Judith Absalon, Sharon Mannheimer, Avis Thomas, Rodger D. MacArthur

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

To benefit maximally from antiretroviral therapy, patients with HIV infection must enter care before their disease is advanced and adhere to care. We sought to determine if and where on this continuum of care racial/ethnic disparities were evident. Data from the Flexible Initial Retrovirus Suppressive Therapies (FIRST) trial, which evaluated three strategies for initial HIV therapy, were compared for White, African American, and Latino subjects. Outcomes included progression of disease and death, HIV viral suppression, and change in CD4+ cell count. Multivariate Cox proportional hazard models adjusted for known predictors of survival. There were 1357 subjects, including 368 non-Latino white, 751 non-Latino African American, and 238 Latino subjects. At baseline, the two latter groups were more likely to have had AIDS and had lower CD4+ cell counts than white subjects. In follow-up, African American subjects had lower self-reported adherence to therapy, lower CD4+ cell count increases, and lower odds of viral suppression. African American and Latino subjects had unadjusted hazard ratios of progression of disease or death of 1.57 (1.17, 2.10; p=0.0025) and 1.57 (1.09, 2.26; p=0.02), respectively. Adjusting for baseline differences and differences in adherence, CD4+ cell count change, and viral suppression accounted for the disparities in outcomes. Opportunities to reduce disparities in outcomes for African American and Latino patients exist along the continuum of HIV care. Efforts to promote access to HIV testing and care and to improve adherence have the potential to reduce racial/ethnic disparities in outcomes of patients with HIV infection.

Original languageEnglish (US)
Pages (from-to)287-295
Number of pages9
JournalAIDS Patient Care and STDs
Volume24
Issue number5
DOIs
StatePublished - May 1 2010

Fingerprint

Retroviridae
Hispanic Americans
African Americans
CD4 Lymphocyte Count
HIV
Continuity of Patient Care
HIV Infections
Disease Progression
Therapeutics
Proportional Hazards Models
Acquired Immunodeficiency Syndrome
Survival

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Disparities in outcomes for African American and Latino subjects in the Flexible Initial Retrovirus Suppressive Therapies (first) trial. / Giordano, Thomas P.; Bartsch, Glenn; Zhang, Yafeng; Tedaldi, Ellen; Absalon, Judith; Mannheimer, Sharon; Thomas, Avis; MacArthur, Rodger D.

In: AIDS Patient Care and STDs, Vol. 24, No. 5, 01.05.2010, p. 287-295.

Research output: Contribution to journalArticle

Giordano, Thomas P. ; Bartsch, Glenn ; Zhang, Yafeng ; Tedaldi, Ellen ; Absalon, Judith ; Mannheimer, Sharon ; Thomas, Avis ; MacArthur, Rodger D. / Disparities in outcomes for African American and Latino subjects in the Flexible Initial Retrovirus Suppressive Therapies (first) trial. In: AIDS Patient Care and STDs. 2010 ; Vol. 24, No. 5. pp. 287-295.
@article{7282a51c3385427eb27bfcee3102cfc1,
title = "Disparities in outcomes for African American and Latino subjects in the Flexible Initial Retrovirus Suppressive Therapies (first) trial",
abstract = "To benefit maximally from antiretroviral therapy, patients with HIV infection must enter care before their disease is advanced and adhere to care. We sought to determine if and where on this continuum of care racial/ethnic disparities were evident. Data from the Flexible Initial Retrovirus Suppressive Therapies (FIRST) trial, which evaluated three strategies for initial HIV therapy, were compared for White, African American, and Latino subjects. Outcomes included progression of disease and death, HIV viral suppression, and change in CD4+ cell count. Multivariate Cox proportional hazard models adjusted for known predictors of survival. There were 1357 subjects, including 368 non-Latino white, 751 non-Latino African American, and 238 Latino subjects. At baseline, the two latter groups were more likely to have had AIDS and had lower CD4+ cell counts than white subjects. In follow-up, African American subjects had lower self-reported adherence to therapy, lower CD4+ cell count increases, and lower odds of viral suppression. African American and Latino subjects had unadjusted hazard ratios of progression of disease or death of 1.57 (1.17, 2.10; p=0.0025) and 1.57 (1.09, 2.26; p=0.02), respectively. Adjusting for baseline differences and differences in adherence, CD4+ cell count change, and viral suppression accounted for the disparities in outcomes. Opportunities to reduce disparities in outcomes for African American and Latino patients exist along the continuum of HIV care. Efforts to promote access to HIV testing and care and to improve adherence have the potential to reduce racial/ethnic disparities in outcomes of patients with HIV infection.",
author = "Giordano, {Thomas P.} and Glenn Bartsch and Yafeng Zhang and Ellen Tedaldi and Judith Absalon and Sharon Mannheimer and Avis Thomas and MacArthur, {Rodger D.}",
year = "2010",
month = "5",
day = "1",
doi = "10.1089/apc.2009.0332",
language = "English (US)",
volume = "24",
pages = "287--295",
journal = "AIDS Patient Care and STDs",
issn = "1087-2914",
publisher = "Mary Ann Liebert Inc.",
number = "5",

}

TY - JOUR

T1 - Disparities in outcomes for African American and Latino subjects in the Flexible Initial Retrovirus Suppressive Therapies (first) trial

AU - Giordano, Thomas P.

AU - Bartsch, Glenn

AU - Zhang, Yafeng

AU - Tedaldi, Ellen

AU - Absalon, Judith

AU - Mannheimer, Sharon

AU - Thomas, Avis

AU - MacArthur, Rodger D.

PY - 2010/5/1

Y1 - 2010/5/1

N2 - To benefit maximally from antiretroviral therapy, patients with HIV infection must enter care before their disease is advanced and adhere to care. We sought to determine if and where on this continuum of care racial/ethnic disparities were evident. Data from the Flexible Initial Retrovirus Suppressive Therapies (FIRST) trial, which evaluated three strategies for initial HIV therapy, were compared for White, African American, and Latino subjects. Outcomes included progression of disease and death, HIV viral suppression, and change in CD4+ cell count. Multivariate Cox proportional hazard models adjusted for known predictors of survival. There were 1357 subjects, including 368 non-Latino white, 751 non-Latino African American, and 238 Latino subjects. At baseline, the two latter groups were more likely to have had AIDS and had lower CD4+ cell counts than white subjects. In follow-up, African American subjects had lower self-reported adherence to therapy, lower CD4+ cell count increases, and lower odds of viral suppression. African American and Latino subjects had unadjusted hazard ratios of progression of disease or death of 1.57 (1.17, 2.10; p=0.0025) and 1.57 (1.09, 2.26; p=0.02), respectively. Adjusting for baseline differences and differences in adherence, CD4+ cell count change, and viral suppression accounted for the disparities in outcomes. Opportunities to reduce disparities in outcomes for African American and Latino patients exist along the continuum of HIV care. Efforts to promote access to HIV testing and care and to improve adherence have the potential to reduce racial/ethnic disparities in outcomes of patients with HIV infection.

AB - To benefit maximally from antiretroviral therapy, patients with HIV infection must enter care before their disease is advanced and adhere to care. We sought to determine if and where on this continuum of care racial/ethnic disparities were evident. Data from the Flexible Initial Retrovirus Suppressive Therapies (FIRST) trial, which evaluated three strategies for initial HIV therapy, were compared for White, African American, and Latino subjects. Outcomes included progression of disease and death, HIV viral suppression, and change in CD4+ cell count. Multivariate Cox proportional hazard models adjusted for known predictors of survival. There were 1357 subjects, including 368 non-Latino white, 751 non-Latino African American, and 238 Latino subjects. At baseline, the two latter groups were more likely to have had AIDS and had lower CD4+ cell counts than white subjects. In follow-up, African American subjects had lower self-reported adherence to therapy, lower CD4+ cell count increases, and lower odds of viral suppression. African American and Latino subjects had unadjusted hazard ratios of progression of disease or death of 1.57 (1.17, 2.10; p=0.0025) and 1.57 (1.09, 2.26; p=0.02), respectively. Adjusting for baseline differences and differences in adherence, CD4+ cell count change, and viral suppression accounted for the disparities in outcomes. Opportunities to reduce disparities in outcomes for African American and Latino patients exist along the continuum of HIV care. Efforts to promote access to HIV testing and care and to improve adherence have the potential to reduce racial/ethnic disparities in outcomes of patients with HIV infection.

UR - http://www.scopus.com/inward/record.url?scp=77952973200&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952973200&partnerID=8YFLogxK

U2 - 10.1089/apc.2009.0332

DO - 10.1089/apc.2009.0332

M3 - Article

C2 - 20438378

AN - SCOPUS:77952973200

VL - 24

SP - 287

EP - 295

JO - AIDS Patient Care and STDs

JF - AIDS Patient Care and STDs

SN - 1087-2914

IS - 5

ER -